The new market for A-shares is about to usher in stocks with extremely high issuance prices. This is Yiqiao Shenzhou.
According to the company’s initial public offering and listing on GEM,The company’s current issue price is 292.92 yuan/share。Yiqiao Shenzhou also set a record for the highest A-share issuance price in history。
The impact of the epidemic on the company’s ability to continue operations attracts attention
Yiqiao Shenzhou is aA biotechnology company engaged in the research and development, production, sales and technical services of biological reagentsThe main business includes products such as recombinant proteins, antibodies, genes and culture media, as well as the development of recombinant proteins and antibodies, and biological analysis and testing services.
According to the latest prospectus of Yiqiao Shenzhou, the company’s customers cover various domestic and foreign biological research and development units, such as universities, scientific research institutes, and pharmaceutical research and development companies. At present, the company has established subsidiaries in the United States and Europe, with a cumulative number of customers exceeding 5,000, and the brand reputation continues to accumulate. During the reporting period, the company’s operating income grew rapidly.Has become one of the leading domestic technology companies in the biological reagent industry。
From a financial point of view, from 2018 to 2020, the operating income of Yiqiao Shenzhou will be 139,227,700 yuan, 180,826,700 yuan, and 159,629,300 yuan, and the net profit attributable to shareholders of the parent company will be 36,353,500 yuan, 36,410,900 yuan, and 112,767,700 yuan, respectively. Yuan.
Regarding the net profit increase of 2969.90% in 2020, Yiqiao Shenzhou stated in the prospectus that the new coronavirus pneumonia epidemic will break out globally in 2020, and the market demand for the company’s new coronavirus-related biological reagent products has increased significantly, and the company’s performance this year has increased significantly .
Yiqiao Shenzhou intends to log on to the Growth Enterprise Market this time, and the company’s listing application was accepted as early as August 2020. As of March this year, it was approved by the GEM Listing Committee. At the listing committee deliberations at that time, issues related to the impact of the new crown epidemic on the company’s ability to continue operations attracted the attention of the GEM Listing Committee, and Yiqiao Shenzhou’s prospectus also pointed out the risk of performance decline.
Yiqiao Shenzhou said in its prospectus, “Although the revenue of non-new crown virus-related products is expected to maintain growth, due to the large uncertainty in the market demand for new crown virus-related products, the company’s overall operating income and operating profit level will be relatively high in 2021. The risk of an annual decline of more than 50%.”
In addition, the issue of whether there is an association between QM92, Qiming Rongxin, Qiming Rongchuang, and Qihua Phase II, the shareholder of Yiqiao Shenzhou, QM92, and whether they are persons acting in concert have also attracted the attention of the GEM Listing Committee.
Nearly 150,000 yuan to be paid for the Form One visa
Before Yiqiao Shenzhou, the three stocks with the highest A-share issue prices were all sci-tech innovation board stocks listed in the past two years, namely Stone Technology (271.12 yuan), Foxit Software (238.53 yuan) and Kangsino (209.71 yuan) .
In this way, the upcoming Yiqiao Shenzhou,Will break the record for the highest issue price of A shares at an issue price of as high as RMB 292.92. If the first one is signed (500 shares), the amount to be paid will also reach 146,460 yuan.
WIND statistics show that in the past two years, there are a total of 6 new stocks with a price higher than 150 yuan. Among the six stocks, the average price increase and decrease on the first day of listing was 89.03%. If calculated at the closing price of the first day, 4 of the 6 ultra-high issue price stocks have a single-sign profit of more than 90,000 yuan, and the highest Zhongwang software contract can earn nearly 130,000 yuan.
From this point of view, Yiqiao China’s single-sign profit is also expected to reach more than 100,000 yuan? On August 1, Wang Jiyue, a veteran investment banker, analyzed in an interview with the reporter of “Daily Economic News” that although Yiqiao Shenzhou’s issuance price is high, in factThe company’s issuance price-earnings ratio is not high, which is still far from the industry average。
According to the prospectus, Yiqiao Shenzhou issued a price-earnings ratio of 17.76 times, and the company’s current industry belongs to the “research and experimental development (M73)” in the “scientific research and technical service industry (M)”. The static average price-earnings ratio of this industry released by China Securities Index Co., Ltd. for the most recent month is 146.05 times (as of July 30, 2021).
In Wang Jiyue’s view, the low issuance price-earnings ratio does not mean that Yiqiao Shenzhou will get a higher increase at the beginning of its listing. Because the cost of buying one hand is too high, there are not many people who are able to participate. In contrast, many new stocks (the first day of listing) have risen far more than 89.03%, and may achieve higher yields. Of course, as a stock with a high issue price, the absolute gains from a single sign Yiqiao Shenzhou may be even greater.
The reporter noticed that if the timeline is stretched a bit longer, the trend of the six ultra-high issue price stocks will also diverge. As of August 1, 2021, since listing, Stone Technology, Kangsino, Hengxuan Technology and Zhongwang Software have all increased by more than 100%, while Foxit Software and Darui Electronics have fallen by 7.65% and 13.86% respectively.
Cover image source: Photograph.com
Real-time query of global new pneumonia epidemic